bendamustine hydrochloride has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gothwal, A; Gupta, U; Kaul, A; Khan, I; Kumar, P; Mishra, AK; Raza, K | 1 |
| Dong, F; Ke, X; Li, H; Wan, W; Wang, J; Wang, Y; Wu, F; Yan, X; Zhang, W; Zhu, M | 1 |
| Arnold, W; Henneberger, G; Nowak, C; Tanneberger, S | 1 |
1 trial(s) available for bendamustine hydrochloride and Experimental Neoplasms
| Article | Year |
|---|---|
[Animal experimental examination of a phase III study on the effect of the combination therapy of bruneomycin, cytostasan and prednisone].
Topics: Animals; Bendamustine Hydrochloride; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Prednisone; Sarcoma, Experimental; Streptonigrin | 1983 |
2 other study(ies) available for bendamustine hydrochloride and Experimental Neoplasms
| Article | Year |
|---|---|
Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Bendamustine Hydrochloride; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Dendrimers; Drug Liberation; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Nanoconjugates; Neoplasms, Experimental; Polyamines; Rats; Rats, Wistar; Tissue Distribution; Treatment Outcome | 2018 |
B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Topics: Animals; Antineoplastic Agents; Apoptosis; B7 Antigens; Bendamustine Hydrochloride; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Silencing; Humans; Lymphoma, Mantle-Cell; Mice; Neoplasms, Experimental; Rituximab | 2015 |